Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00787
|
|||||
| Drug Name |
PDX-101
|
|||||
| Synonyms |
(2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide; (E)-N-hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide; (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide; 414864-00-9; 866323-14-0; Beleodaq; Belinostat; Belinostat (PXD101); Belinostat(Random Configuration); CHEBI:61076; F4H96P17NZ; N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE; N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE; NSC726630; PX 105684; PX-105684; PX105684; PXD 101; PXD-101; PXD101; UNII-F4H96P17NZ
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H14N2O4S
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO
|
|||||
| InChI |
InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+
|
|||||
| InChIKey |
NCNRHFGMJRPRSK-MDZDMXLPSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 318.3 | Topological Polar Surface Area | 104 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
1.7
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.